Epoxidized fatty acid alkyl ester plasticizers and methods for making epoxidized fatty acid alkyl ester plasticizers

Information

  • Patent Grant
  • 9499681
  • Patent Number
    9,499,681
  • Date Filed
    Monday, November 12, 2012
    11 years ago
  • Date Issued
    Tuesday, November 22, 2016
    7 years ago
Abstract
Epoxidized fatty acid alkyl esters and methods for making epoxidized fatty acid alkyl esters. Such epoxidized fatty acid alkyl esters can be prepared by epoxidizing fatty acid alkyl esters with an acid and a peroxide. Epoxidation can be performed under controlled reaction conditions to provide epoxidized fatty acid alkyl esters having an iodine value in the range of from 4 to 15 g I2/100 g of epoxidized fatty acid alkyl esters. Epoxidized fatty acid alkyl esters can be employed in plasticizer compositions, either alone or in combination with other plasticizers, such as epoxidized natural oils. Such plasticizers in turn may be used in the formation of polymeric compositions.
Description
FIELD

Various embodiments of the present invention relate to methods for making epoxidized fatty acid alkyl esters. Such epoxidized fatty acid alkyl esters may be employed as plasticizers or in plasticizer compositions.


INTRODUCTION

Plasticizers are compounds or mixtures of compounds that, when added to polymer resins, can lower one or more of the modulus and tensile strength, and increase one or more of flexibility, elongation, impact strength, and tear strength of the resin (typically a thermoplastic polymer) to which they are added. A plasticizer may also lower the melting point of the polymer resin, which lowers the glass transition temperature and enhances processability of the polymer resin.


Phthalic acid diesters (also known as “phthalates”) are commonly used as plasticizers in many flexible polymer products, such as polymer products formed from polyvinyl chloride (“PVC”) and other vinyl polymers. Examples of phthalate plasticizers include diisononyl phthalate, diallyl phthalate, di-2-ethylhexyl-phthalate, dioctyl phthalate, and diisodecyl phthalate. Other plasticizers used for high temperature applications are trimellitates and adipic polyesters.


Phthalate plasticizers have recently come under intense scrutiny by public interest groups concerned about the negative environmental impact of phthalates and potential adverse health effects in humans exposed to phthalates. Accordingly, plasticizers that minimize or eliminate the use of phthalates are needed. Although advancements have been made, improvements in such plasticizers are still desired.


SUMMARY

One embodiment is a plasticizer composition comprising: epoxidized fatty acid alkyl esters, wherein said epoxidized fatty acid alkyl esters have an iodine value in the range of from 4 to 15 g I2/100 g of epoxidized fatty acid alkyl esters.


Another embodiment is a process for producing epoxidized fatty acid alkyl esters, said process comprising: epoxidizing fatty acid alkyl esters via controlled epoxidation by contact with an acid and an aqueous peroxide solution to form epoxidized fatty acid alkyl esters, wherein said controlled epoxidation comprises selecting a reaction temperature, a reaction time, an aqueous peroxide solution concentration, and a peroxide solution feed rate to cause said epoxidized fatty acid alkyl esters to retain sufficient unsaturation to present an iodine value in the range of from 4 to 15 g I2/100 g of epoxidized fatty acid alkyl esters.







DETAILED DESCRIPTION

Various embodiments of the present invention concern methods for preparing epoxidized fatty acid alkyl esters (“eFAAE”) from esterified natural oils. Such eFAAEs can be employed as a plasticizer alone or in combination with an epoxidized natural oil (“eNO”). Plasticizers comprising eFAAE and optionally eNO can be employed with a variety of polymeric resins and in making various articles of manufacture.


Preparing Epoxidized Fatty Acid Alkyl Esters


The eFAAE can be prepared by epoxidation of an esterified (e.g., transesterified) natural oil. Thus, in one or more embodiments, the eFAAE can be prepared by first subjecting a natural oil to esterification (e.g., transesterification), thereby producing fatty acid alkyl esters. The term “natural oil” denotes an oil comprising fatty acid triglycerides and is derived from a microbe (algae, bacteria), a plant/vegetable, and/or a seed. In an embodiment, the natural oil includes genetically-modified natural oil. In another embodiment, the natural oil excludes petroleum-derived oil. Non-limiting examples of suitable natural oils include algae oil, beef tallow oil, canola oil, castor oil, corn oil, fish oil, linseed oil, palm oil, rapeseed oil, safflower oil, soybean oil, sunflower oil, tall oil, tung oil, and combinations of two or more thereof. In an embodiment, the natural oil is selected from the group consisting of soybean oil, canola oil, linseed oil, and combinations thereof. In an embodiment, the natural oil is soybean oil. In an embodiment, the natural oil has a linolenic acid content of greater than 5 weight percent (“wt %”).


In an embodiment, esterification of the natural oil is performed via transesterification. Transesterification can be performed using any conventional or hereafter discovered techniques. In an embodiment, the natural oil is transesterified via contact with an alcohol under transesterification conditions with either an acid or base catalyst. Glycerol byproduct is removed from the reaction products due to insolubility. The alcohol employed for transesterification is selected based on the desired alkyl substituent of the fatty acid alkyl esters. Alcohols suitable for use in transesterification include C1 to C8 monohydric linear alcohols, such as methanol, ethanol, propanol, and butanol, or C3 to C8 branched alcohols, such as isopropanol, isobutanol, and 2-ethylhexanol. In an embodiment, the alcohol is methanol, such that the resultant fatty acid alkyl esters are fatty acid methyl esters.


In an embodiment, the fatty acid alkyl esters have the structure: R1—C(═O)O—R2, where R1 is a linear or branched C1 to C8 alkyl group, and R2 represents one or more of saturated, mono-unsaturated, and polyunsaturated C12 to C22 fatty acid chains.


A catalyst may also be employed for esterification (e.g., transesterification). Catalysts suitable for use in esterification include homogeneous alkali catalysts, including metal alkoxides such as sodium methoxide, potassium methoxide, and sodium ethoxide, or metal hydroxides such as potassium hydroxide, sodium hydroxide, or supported solid alkali catalysts. Other classes of catalysts that may also be employed include acids, acidic resins, double metal cyanide catalysts, enzymes, super acids, super bases, and metal salts. The catalyst can be in homogeneous or heterogeneous form. In an embodiment, the catalyst employed for transesterification is sodium methoxide solution in methanol.


Commercially available FAAEs may be employed in various embodiments. Examples of suitable commercially available FAAEs include SOYCLEAR™ 1500 and SOYGOLD™ 1100 (fatty acid methyl esters from soybean oil, available from AG Environmental Products, Inc.); CANOLAGOLD™ 110 (fatty acid methyl esters from canola oil, available from AG Environmental Products, Inc.); and SE-1885 and SE-1885D (fatty acid methyl esters from soybean oil, available from Felda Iffco, Inc.).


The fatty acid alkyl esters are then epoxidized via contact with an acid and an aqueous peroxide solution to thereby produce an epoxidized reaction mixture comprising epoxidized fatty acid alkyl esters, residual acid, residual peroxide, and water. Suitable peroxides for use in epoxidizing the natural oil include aqueous solutions of hydrogen peroxide, peroxycarboxylic acids, alkyl hydroperoxides, and tertiary hydroperoxides. In an embodiment, the peroxide employed is an aqueous solution of hydrogen peroxide.


Suitable acids for use in epoxidizing the fatty acid alkyl esters include carboxylic acids, such as formic acid and acetic acid; and peroxycarboxylic acids, such as performic acid and peracetic acid. In an embodiment, a peroxycarboxylic acid is employed, acting as both the acid and the peroxide. Catalysts such as mineral acids (e.g., sulfuric acid) and heterogeneous acid resins (e.g., Amberlite™ IR 120H, available from Rohm & Haas) may optionally be employed in the presence of the acid. In an embodiment, the acid employed for epoxidation is formic acid.


In one or more embodiments, the epoxidation reaction is controlled so as to produce eFAAEs having an iodine value in the range of from 4 to 15 grams of iodine per 100 grams of epoxidized fatty acid alkyl esters (“g I2/100 g”), in the range of from 4 to 10 g I2/100 g, in the range of from 7 to 10 g I2/100 g, or in the range of from 8 to 10 g I2/100 g. Iodine value is determined according to the American Oil Chemists' Society (“AOCS”) recommended practice Cd 1-25. Additionally, the controlled epoxidation reaction conditions can be selected so as to produce eFAAEs having an oxirane oxygen content of at least 6 wt %, or at least 6.5 wt %, based on the entire weight of the eFAAEs. In various embodiments, the eFAAEs can have an oxirane oxygen content up to 8 wt %, or 7.5 wt %, based on the entire weight of the eFAAEs. Oxirane oxygen content is determined according to AOCS recommended practice Cd 9-57.


Controlled epoxidation comprises selecting a combination of reaction temperature, reaction time, aqueous peroxide solution concentration, molar ratio of peroxide-to-carbon/carbon double bonds, and peroxide solution feed rate to achieve the desired iodine value and/or oxirane oxygen content. In an embodiment, the epoxidation reaction temperature employed can be maintained in the range of from 20 to 60° C., in the range of from 30 to 50° C., or in the range of from 40 to 50° C. In various embodiments, the aqueous peroxide solution employed can have a concentration of less than 50 volume percent (“vol %”), less than 40 vol %, in the range of from 20 to 40 vol %, in the range of from 25 to 35 vol %, or of 30 vol %. In one or more embodiments, the molar ratio of peroxide-to-carbon/carbon double bounds in the FAAE can be from 1.5 to 2, from 1.7 to 2, or 2. In an embodiment, the peroxide solution feed rate can range from 0.2 to 2 grams of peroxide solution per gram of fatty acid alkyl esters per hour. In another embodiment, the peroxide solution feed rate can range from 0.3 to 4 moles of peroxide solution per molar equivalent of carbon-carbon double bonds in the fatty acid alkyl esters per hour. Regardless of which measurement is employed for determining the peroxide solution feed rate, in an embodiment, the peroxide solution feed rate can be controlled so that the epoxidation reaction temperature does not exceed the desired maximum temperature described above. In an embodiment, the peroxide feed rate can be controlled so as to prevent the epoxidation reaction temperature from exceeding 60° C., 50° C., or 40° C.


In some embodiments, the reaction conditions chosen to maintain the above-described iodine value may cause decreased oxirane oxygen content. In order to achieve the desired oxirane oxygen content (e.g., at least 6 or at least 6.5 wt %), a longer-than-conventional reaction time may be employed. In various embodiments, the reaction time employed for controlled epoxidation can be greater than 6 hours, in the range of from 7 to 20 hours, in the range of from 8 to 15 hours, or in the range of from 10 to 12 hours.


Though not wishing to be bound by theory, it was surprisingly found that maintaining an iodine value of at least 4 produces eFAAE having low concentrations of hydrophilic impurities compared to conventional eFAAE. The term “hydrophilic impurities” denotes epoxidized fatty acid ester compounds containing hydroxyl groups formed from degraded epoxy rings on the fatty acid chain. In an embodiment, the eFAAE can have a hydrophilic impurities content of less than 0.8 wt %, less than 0.7 wt %, less than 0.6 wt %, less than 0.5 wt %, less than 0.4 wt %, less than 0.3 wt %, less than 0.2 wt %, or less than 0.1 wt % based on the entire weight of the eFAAE. Hydrophilic impurities content is determined by high performance liquid chromatography (“HPLC”) according to the test method described in the following Examples.


Following epoxidation, the residual acid, peroxide, and water is removed from the epoxidized reaction mixture via layer separation and neutralization. Layer separation involves separation of an aqueous layer, which contains water, acids, peroxide, and possible traces of oil and esters, from an organic layer containing the eFAAE. To accomplish layer separation, the reaction mixture is allowed to settle and separate into two layers by density difference, and the bottom aqueous layer is disposed of while the top organic layer is processed further to obtain the desired product.


Following layer separation, the residual acid can be neutralized, such as by contact with a sodium/bicarbonate solution. Thereafter, the organic layer can be washed one or more times with water. In an embodiment, the organic layer is washed repeatedly until it is neutral (having a pH of about 7). Thereafter, the washed mixture can be subjected to layer separation again, followed by vacuum distillation of the top organic layer to remove residual water.


Plasticizer


The present disclosure provides a plasticizer composition comprising eFAAE, prepared as described above. Optionally, the plasticizer composition can further include other types of plasticizers, such as an eNO. Suitable epoxidized natural oils include epoxidized animal and vegetable oils, such as epoxidized soybean oil (“eSO”), epoxidized corn oil, epoxidized sunflower oil, epoxidized palm oil, epoxidized linseed oil, epoxidized canola oil, epoxidized rapeseed oil, epoxidized safflower oil, epoxidized tall oil, epoxidized tung oil, epoxidized fish oil, epoxidized beef tallow oil, epoxidized castor oil, or combinations thereof. In an embodiment, the present plasticizer is a phthalate-free plasticizer, or is otherwise void or substantially void of phthalate.


When both eFAAE and eNO are present, the plasticizer composition can contain relative amounts of eFAAE (e.g., eFAME) to eNO (e.g., eSO) in a weight ratio in the range of from greater than (“>”) 0: less than (“<”) 100 to <100:>0, more typically from 10:90 to 90:10, more typically from 20:80 to 80:20, and even more typically from 30:70 to 70:30. In another embodiment, the plasticizer composition comprises from 20 to less than 100 wt % eFAAE and from greater than 0 to 80 wt % eSO. Weight ratios and weight percents are based on total weight of the plasticizer composition. In various embodiments, the plasticizer composition consists of or consists essentially of eFAAE and eNO.


Polymeric Composition


The present disclosure provides a polymeric composition. In an embodiment, a polymeric composition is provided which includes a polymeric resin and the present plasticizer as disclosed above.


Non-limiting examples of suitable polymeric resins include polysulfides, polyurethanes, acrylics, epichlorohydrins, nitrile rubber, chlorosulfonated polyethylene, chlorinated polyethylene, polychloroprene, styrene butadiene rubber, natural rubber, synthetic rubber, EPDM rubber, propylene-based polymers, ethylene-based polymers, and vinyl chloride resins. The term, “propylene-based polymer,” as used herein, is a polymer that comprises a majority weight percent polymerized propylene monomer (based on the total amount of polymerizable monomers), and optionally may comprise at least one polymerized comonomer. The term, “ethylene-based polymer,” as used herein, is a polymer that comprises a majority weight percent polymerized ethylene monomer (based on the total weight of polymerizable monomers), and optionally may comprise at least one polymerized comonomer.


The term “vinyl chloride resin,” as used herein, is a vinyl chloride polymer, such as polyvinyl chloride (“PVC”), or a vinyl chloride copolymer such as vinyl chloride/vinyl acetate copolymer, vinyl chloride/vinylidene chloride copolymer, vinyl chloride/ethylene copolymer or a copolymer prepared by grafting vinyl chloride onto ethylene/vinyl acetate copolymer. The vinyl chloride resin can also include a polymer blend of the above-mentioned vinyl chloride polymer or vinyl chloride copolymer with other miscible or compatible polymers including, but not limited to, chlorinated polyethylene, thermoplastic polyurethane, olefin polymers such as a methacryl polymer or acrylonitrile-butadiene-styrene polymer.


In an embodiment, the polymeric resin is PVC.


In an embodiment, the polymeric composition includes from 25 wt % to 90 wt % PVC, from 5 wt % to 35 wt % eFAAE, from 0 wt % to 35 wt % eNO, and from 0 wt % to 35 wt % filler.


Additives


The polymeric composition may include one or more of the following optional additives: a filler, an antimicrobial agent, a biocide, a flame retardant, a heat stabilizer, an anti-drip agent, a colorant, a lubricant, a low molecular weight polyethylene, a hindered amine light stabilizer, a UV light absorber, a curing agent, a booster, a retardant, a processing aid, a coupling agent, an antistatic agent, a nucleating agent, a slip agent, a viscosity control agent, a tackifier, an anti-blocking agent, a surfactant, an extender oil, an acid scavenger, a metal deactivator, and any combination thereof.


In an embodiment, the polymeric composition includes PVC, the present plasticizer, a filler (calcium carbonate, clays, silica, and any combination thereof), metal soap stabilizers (zinc stearate or mixed metal soap stabilizers containing Ca, Zn, Mg, Sn, and any combination thereof), a phenolic or related antioxidant, and a processing aid.


Articles of Manufacture


Articles of manufacture can be prepared that comprise the above-described polymeric compositions. Such articles of manufacture can include those designed for use in the medical or food industries, particularly those articles that may frequently come into contact with water and where water-leachable compounds are a concern. Exemplary articles of manufacture include blood bags, intravenous bags, saline solution bags, syringes, intravenous tubing, nasogastric tubing, catheter tubing, drainage tubing, examination gloves, oxygen masks, orthodontic retainers, artificial skin, and food packaging (e.g., packaging for various beverages, meats, and frozen vegetables).


TEST METHODS

Hydrophilic Impurities Measurement


Quantify the amount of water-leachable (i.e., hydrophilic) impurities using HPLC with an evaporative light-scattering detector (“ELSD”). The method is as follows:


1) Add 0.04 g of eFAME (liquid) to 8 g of deionized water;


2) Heat the sample in an oven at 40° C. for 24 hours;


3) Remove 1 mL of the sample from the bottom of the vial;


4) Perform HPLC-ELSD for each sample.














HPLC setup:










Mobile phase:
H2O/Acetonitrile (A/B)



Column:
ODS C-18; 2.1 × 100 mm, 3 μm particle size












Gradient:
Time (min)
% B (Acetonitrile)





0.0
88





1.8
88





2.6
100





7.0
100





9.0
88





11.0
88











Flow:
0.30 ml/min.



Oven Temp.:
70° C.



Injection:
2 μl



Run Time:
11 min.



Post Time:
2 min.







ELSD setup:










Instrument:
Alltech 3300 ELSD



Tube Temp.:
70° C.



Gas Flow:
1.80 SLPM



Gain:
1.0



N2 regulator:
60 psig










Oxirane Oxygen Content


Determine oxirane oxygen content according to AOCS Cd 9-57.


Iodine Value


Determine iodine value according to AOCS Cd 1-25.


EXAMPLES
Example 1

Charge 50 g of FAME (SOYCLEAR™ 1500, available from AG Environmental Products, Inc.) and 5.8 g of formic acid (98-100% purity, obtained from RANKEM, RFCL Ltd.) to a 250-mL glass reactor equipped with an overhead stirrer having TEFLON™ blades and immersed in an oil bath having an initial temperature of 30° C. The amounts of FAME and formic acid employed achieve an acid-to-carbon/carbon double bond (“C═C”) mole ratio of 0.5. Add 57.5 g of 30 vol % hydrogen peroxide (“H2O2”) (obtained from Merck & Co.) solution (in water), resulting in an H2O2-to-C═C mole ratio of 2. Add the H2O2 at a continuous rate for the initial 2 hours; maintain reaction temperature at 40° C. by adjusting the temperature of the oil bath. Agitate the reaction mixture via the overhead stirrer at 400 rpm to ensure proper mixing in the reactor. Maintain the reaction conditions for a total of 11 hours, including feeding time. After 11 hours, stop the agitation and allow the reaction mixture to separate into aqueous (bottom) and organic (top) layers over 2 hours. Drain the resulting aqueous layer to separate most of the water and formic acid. Neutralize the organic layer with dilute sodium bicarbonate solution (0.1 M solution prepared by dissolving 8.4 g of sodium bicarbonate powder obtained from S.d. fine Chem in 1 liter of distilled water), which essentially removes residual formic acid. A total of 75 mL of 0.1 M sodium bicarbonate solution is added in 5 steps for neutralization. Thereafter, wash the organic layer with water, repeating until it becomes neutral (approximately 25 mL of water, total). Measure the pH of the wash water after each wash using pH paper; continue washing until it reaches a pH value of about 7. After the last wash, add 50 mL of distilled water to a separating funnel containing the organic layer. Shake the mixture to ensure adequate contact and allow the mixture to settle. Once separation is achieved, drain the bottom aqueous layer. Place the top organic layer under vacuum (˜10 mbar (1,000 Pa), 60° C.) for two hours to remove residual water.


Example 2

Prepare an eFAME sample as described above in Example 1, except employ FAME prepared via transesterification of soybean oil as the starting material. Prepare FAME according to the following method. Charge 100 g (0.113 moles) of soybean oil (obtained from Cargill Gemini) to a 500-mL, 3-neck, round-bottom flask. Add 21.72 g (0.68 moles) of methanol (99.5% pure, obtained from Sigma Aldrich) to the reactor to maintain the mole ratio of methanol:soybean oil at 6:1. The reactor is equipped with a condenser, temperature sensor, and overhead stirrer having TEFLON™ blades. The reactor is immersed in an oil bath to maintain the reaction temperature at 60° C. under nitrogen flow. Once the reaction temperature of 60° C. is achieved, 4 g of 25% sodium methoxide dissolved in methanol (commercially available from Sigma Aldrich) is added to the reactor. After the reaction, wash the reaction mixture with water several times (till pH becomes about 7) to remove the residual sodium methoxide. Dry the final product under vacuum (10 mbar at 60° C.) to obtain FAME.


Example 3

Prepare an eFAME sample according to the method described in Example 1 using the starting material as prepared in Example 2, except maintain the epoxidation reaction temperature at 50° C. instead of 40° C.


Comparative Example 1

Prepare and eFAME sample by charging 50 g of FAME (as prepared in Example 2) and 5.8 g of formic acid to a glass reactor (acid-to-C═C mole ratio of 0.5) equipped as described in Example 1. Add 34.5 g of 50 vol % H2O2 (obtained from Merck) solution (in water), giving an H2O2-to-C═C mole ratio of 2, and at a continuous rate while agitating the reaction mixture and maintaining the reaction temperature between 60 and 70° C. After 6 hours of reaction time, stop the agitation and allow the reaction mixture to separate into aqueous and organic layers for 2 hours. The remaining steps are repeated as described in Example 1.


Comparative Example 2

Prepare and eFAME sample by charging 50 g of FAME (SOYCLEAR™ 1500) and 5.8 g of formic acid to a glass reactor (acid-to-C═C mole ratio of 0.5) equipped as described in Example 1. Add 34.5 g of 50 vol % H2O2 (obtained from Merck) solution (in water), giving an H2O2-to-C═C mole ratio of 2, and at a continuous rate while agitating the reaction mixture and maintaining the reaction temperature at 60° C. After 3 hours of reaction time, stop the agitation and allow the reaction mixture to separate into aqueous and organic layers for 2 hours. The remaining steps are repeated as described in Example 1.


Analyses


For each of the samples prepared as described above, determine the oxirane oxygen content according to the above-described procedure. Additionally, determine the iodine number for each sample according to the above-described procedure. Finally, determine the hydrophilic impurities content for each sample according to the above-described procedure. Results of these analyses are provided in Table 1, below.









TABLE 1







Sample Properties
















Comp.
Comp.


Property
Ex. 1
Ex. 2
Ex. 3
Ex. 1
Ex. 2















Oxirane oxygen (wt %)
6.51
6.50
6.97
6.09
6.74


Iodine number (g I2/
8.29
9.91
4.16
1.65
3.19


100 g)







Hydrophilic impurities
0.081
0.083
0.14
1.6
0.98


(wt %)







Percent change in
−92
−92
−86
+64



hydrophilic







impurities relative







to Comp. Ex. 2









As can be seen from the results in Table 1, the amount of hydrophilic impurities in eFAME Examples 1 and 2 was reduced by more than 90% when the iodine number was increased to between 8 and 10 from 3.2. The hydrophilic impurities content was also reduced by more than 85% when the iodine number was increased to above 4 from 3.2, as seen in Example 3. On the other hand, when the iodine number was decreased further to 1.6, hydrophilic impurities increased by more than 60%, as shown in Comparative Example 1.

Claims
  • 1. A plasticizer composition comprising: epoxidized fatty acid alkyl esters,wherein said epoxidized fatty acid alkyl esters have an iodine value in the range of from 7 to 10 g I2/100 g of epoxidized fatty acid alkyl esters,wherein said epoxidized fatty acid alkyl esters have an oxirane oxygen content of at least 6 weight percent based on the entire weight of the epoxidized fatty acid alkyl esters,wherein said epoxidized fatty acid alkyl esters are prepared from esterified soybean oil,wherein said epoxidized fatty acid alkyl esters have a hydrophilic impurities content of less than 0.8 weight percent based on the entire weight of said epoxidized fatty acid alkyl esters.
  • 2. A polymeric composition comprising a polymeric resin and the plasticizer composition of claim 1.
  • 3. The polymeric composition of claim 2, wherein said polymeric resin is a vinyl chloride resin, wherein said polymeric composition is an article of manufacture selected from the group consisting of blood bags, intravenous bags, saline solution bags, syringes, intravenous tubing, nasogastric tubing, catheter tubing, drainage tubing, examination gloves, oxygen masks, orthodontic retainers, artificial skin, and food packaging.
  • 4. A process for producing epoxidized fatty acid alkyl esters, said process comprising: epoxidizing fatty acid alkyl esters via controlled epoxidation by contact with an acid and an aqueous peroxide solution to form epoxidized fatty acid alkyl esters,wherein said controlled epoxidation comprises selecting a reaction temperature, a reaction time, an aqueous peroxide solution concentration, and a peroxide solution feed rate to cause said epoxidized fatty acid alkyl esters to retain sufficient unsaturation to present an iodine value in the range of from 7 to 10 g I2/100 g of epoxidized fatty acid alkyl esters,wherein said epoxidized fatty acid alkyl esters have an oxirane oxygen content of at least 6 weight percent based on the entire weight of the epoxidized fatty acid alkyl esters,wherein said fatty acid alkyl esters are prepared by transesterifying a soybean oil,wherein said epoxidized fatty acid alkyl esters have a hydrophilic impurities content of less than 0.8 weight percent based on the entire weight of said epoxidized fatty acid alkyl esters.
  • 5. The process of claim 4, wherein said reaction temperature is in the range of from 30 to 50° C., wherein said aqueous peroxide solution has a concentration of less than 40%, wherein said reaction time is greater than 6 hours, wherein said peroxide solution feed rate is in the range of from 0.3 to 4 moles of peroxide solution per molar equivalent of carbon-carbon double bonds in the fatty acid alkyl esters per hour.
  • 6. The process of claim 4, wherein said epoxidized fatty acid alkyl esters have the structure: R1—C(═O)O—R2, wherein R1 is a linear or branched C1 to C8 alkyl group, and R2 represents saturated, mono-unsaturated, and/or polyunsaturated C12 to C22 epoxidized fatty acid chains.
PCT Information
Filing Document Filing Date Country Kind
PCT/IN2012/000746 11/12/2012 WO 00
Publishing Document Publishing Date Country Kind
WO2014/072987 5/15/2014 WO A
US Referenced Citations (80)
Number Name Date Kind
2397592 Blades Apr 1946 A
2403215 Foster Jul 1946 A
2458484 Terry et al. Jan 1949 A
2500918 Rueter et al. Mar 1950 A
2618622 Grummit et al. Nov 1952 A
2666752 Grummit et al. Jan 1954 A
3138566 Arnold Jun 1964 A
3254097 Darrow May 1966 A
3377304 Kuester Apr 1968 A
3409580 Alzner Nov 1968 A
3451958 Riedeman et al. Jun 1969 A
3639318 Tijunelis et al. Feb 1972 A
3668091 French et al. Jun 1972 A
3712875 Tijunelis Jan 1973 A
3778465 Barnstorf Dec 1973 A
3780140 Hammer Dec 1973 A
3868341 Sauer et al. Feb 1975 A
3872187 Fath Mar 1975 A
3891694 Mills et al. Jun 1975 A
4083816 Frankel et al. Apr 1978 A
4346145 Choi et al. Aug 1982 A
4421886 Worschech et al. Dec 1983 A
4426477 Yasumatsu et al. Jan 1984 A
4556694 Wallace Dec 1985 A
4605694 Walker Aug 1986 A
4612192 Scheuffgen et al. Sep 1986 A
4613533 Loomis et al. Sep 1986 A
4627993 Loomis Dec 1986 A
4670494 Semenza, Jr. Jun 1987 A
4857600 Gross et al. Aug 1989 A
5225108 Bae et al. Jul 1993 A
5227417 Kroushl, III Jul 1993 A
5246783 Spenadel et al. Sep 1993 A
5270366 Hein Dec 1993 A
5278236 Case et al. Jan 1994 A
5430108 Schlosberg et al. Jul 1995 A
5454806 Shinonome Oct 1995 A
5464903 Hofmann Nov 1995 A
5466267 Baillargeon et al. Nov 1995 A
5575965 Caronia et al. Nov 1996 A
5736605 Oshima Apr 1998 A
5756570 Hoch et al. May 1998 A
5886072 Linsky et al. Mar 1999 A
6063846 Weng et al. May 2000 A
6114425 Day et al. Sep 2000 A
6274750 Sato et al. Aug 2001 B1
6417260 Weng et al. Jul 2002 B1
6437170 Thil et al. Aug 2002 B1
6451958 Fan et al. Sep 2002 B1
6495033 Talboom Dec 2002 B1
6496629 Ma et al. Dec 2002 B2
6608142 Weng et al. Aug 2003 B1
6706815 Marchand et al. Mar 2004 B2
6714707 Rossi et al. Mar 2004 B2
6734241 Nielsen et al. May 2004 B1
6797753 Benecke et al. Sep 2004 B2
6849694 Hata Feb 2005 B2
6949597 Nielsen et al. Sep 2005 B2
7700675 Bueno de Almeida et al. Apr 2010 B2
20020013396 Benecke et al. Jan 2002 A1
20040122159 Mhetar et al. Jun 2004 A1
20050090590 Nielsen et al. Apr 2005 A1
20050203230 Kadakia et al. Sep 2005 A1
20060025544 Koube et al. Feb 2006 A1
20060276575 Hamaguchi et al. Dec 2006 A1
20070100049 Ishizuka May 2007 A1
20070135562 Freese et al. Jun 2007 A1
20080200595 Hinault Aug 2008 A1
20080227993 Zuckerman Sep 2008 A1
20090149585 De Quadros Junior et al. Jun 2009 A1
20090149586 De Quadros Junior et al. Jun 2009 A1
20090312478 Hasegawa et al. Dec 2009 A1
20100010127 Barki et al. Jan 2010 A1
20100256278 Harada et al. Oct 2010 A1
20110076502 Chaudhary et al. Mar 2011 A1
20110272174 Chaudhary Nov 2011 A1
20120181058 Chaudhary Jul 2012 A1
20120289727 Cordeiro Nov 2012 A1
20130005937 Cramail et al. Jan 2013 A1
20130123408 Maurer May 2013 A1
Foreign Referenced Citations (57)
Number Date Country
1188445 Jun 1985 CA
1341681 Mar 2002 CN
101070510 Nov 2007 CN
101108982 Jan 2008 CN
101445495 Jun 2009 CN
101591588 Dec 2009 CN
101824193 Sep 2010 CN
101891713 Nov 2010 CN
101914219 Dec 2010 CN
0192961 Sep 1986 EP
0358179 Mar 1990 EP
0364717 Apr 1990 EP
0 393 813 Oct 1990 EP
0473915 Mar 1992 EP
0565984 Oct 1993 EP
0986606 Mar 2000 EP
1218443 Jul 2002 EP
1361039 Nov 2003 EP
1624014 Feb 2006 EP
2070977 Jun 2009 EP
2245089 Nov 2010 EP
1437722 May 1966 FR
102292 Nov 1916 GB
499931 Jan 1939 GB
790314 Feb 1958 GB
910543 Nov 1962 GB
934689 Aug 1963 GB
1020866 Feb 1966 GB
1102506 Feb 1968 GB
1341623 Dec 1973 GB
2155021 Sep 1985 GB
S44-007131 Mar 1969 JP
S61-016950 Jan 1986 JP
04-059851 Feb 1992 JP
H04-085354 Mar 1992 JP
H04-261452 Sep 1992 JP
2000-319468 Nov 2000 JP
2003-064233 Mar 2003 JP
2003-297149 Oct 2003 JP
2004311064 Nov 2004 JP
2010-042669 Feb 2010 JP
9730115 Aug 1997 WO
0114466 Mar 2001 WO
0198404 Dec 2001 WO
2004052977 Jun 2004 WO
2007006489 Jan 2007 WO
2008081330 Jul 2008 WO
2008081332 Jul 2008 WO
2008122364 Oct 2008 WO
2009102877 Aug 2009 WO
2011041380 Apr 2011 WO
2011041388 Apr 2011 WO
2011041372 Apr 2011 WO
WO2011041396 Apr 2011 WO
WO2011072346 Jun 2011 WO
WO2012015997 Feb 2012 WO
2013003225 Jan 2013 WO
Non-Patent Literature Citations (67)
Entry
European Commission Opinion on Medical Devices Containing DEHP Plasticized PVC; Neonates and Other Groups Possibly at Risk from DEHP Toxicity, 2002, p. 1-34.
PCT/IN2012/000745, International Preliminary Report on Patentability, Issued May 12, 2015.
PCT/US2013/039841, International Search Report and Written Opinion, Mailed Mar. 27, 2014.
PCT/US2013/039841, International Preliminary Report on Patentability, Issued Dec. 21, 2014.
PCT/IN2012/00688, International Search Report and Written Opinion, Mailed Jun. 18, 2013.
PCT/IN2012/00688, International Preliminary Report on Patentability, Issued Apr. 30, 2015.
PCT/IN2012/000746 International Search Report and Written Opinion, Mailed May 31, 2013.
PCT/IN2012/000746, International Preliminary Report on Patentability, Issued May 12, 2015.
PCT/US2013/039840 International Search Report and Written Opinion, Mailed Jul. 11, 2013.
PCT/US2013/039840, International Preliminary Report on Patentability, Issued Dec. 31, 2014.
PCT/US2014/020556 International Search Report and Written Opinion, Mailed Jun. 25, 2014.
PCT/US2010/050654, International Preliminary Report on Patentability, Issued Mar. 31, 2012.
PCT/US2010/050676, International Preliminary Report on Patentability, Issued Mar. 31, 2012.
PCT/US2011/045653, International Preliminary Report on Patentability, Issued Jan. 28, 2013.
PCT/US2012/043740, International Preliminary Report on Patentability, Issued Jan. 7, 2014.
PCT/US2012/055070, International Preliminary Report on Patentability, Issued Apr. 1, 2014.
PCT/US2010/050669, International Preliminary Report on Patentability, Issued Apr. 11, 2012.
PCT/US2011/035143, International Preliminary Report on Patentability, Issued Nov. 10, 2012.
http://en.wikipedia.org/wiki/Chlorine.
http://en.wikipedia.org/wiki/Bleaching—of—wood—pulp.
TCI America, Online Catalog: Tributyrin; http://web.archive.org/web/20080511154307/http://www.tciamerica.com/.
PCT/ US2009/033935, International Preliminary Report on Patentability, MailedAug. 26, 2010.
PCT/US2009/033935 International Search Report and Written Opinion, Mailed Mailed May 18, 2009.
PCT/US2010/050654 International Search Report and Written Opinion Mailed Nov. 9, 2010.
PCT/US2010/050676 International Search Report and Written Opinion Mailed Jan. 12, 2011.
PCT/US2010/050690 International Preliminary Report on Patentability, Mailed Jan. 12, 2012
PCT/US2010/050690 International Search Report and Written Opinion, Mailed Aug. 2, 2011.
PCT/US2010/050699 International Search Report and Written Opinion, Mailed Nov. 8, 2010.
PCT/US2011/035143 International Search Report and Written Opinion, Mailed Aug. 26, 2011.
Barnicoat, C.R. 1945. Reactions and properties of annatto as a cheese colour. Part II. J. Dairy Res. 14: 59-63.
Bizzari, S.N. et al (2003), Plasticizers. CEH Marketing Research Report, 38-64, Retrieved from http://www.sriconsulting.com.
Campanella A. et al.; High Yield Epoxidation of Fatty Acid Methyl Esters with Performic Acid Generated in Situ; Chemical Engineering Journal, 144 (2008) 466-475 (Elsevier B.V.).
Chuanshang Cai, et al.; Studies on the Kinetics of In Situ Epoxidation of Vegetable Oils; Eur. J. Lipid Sci. Technol., 2008, 110, 341-346 (Wiley-VCH GmbH & Co. KGaA, Weinheim).
Corrigan, Brian Oil purification, filtration and reclamation, Iron Age (1947) 159(14).
Danisco, Grindsted Soft-n-Safe brochure (date unknown).
Du G., et al., Catalytic Epoxidation of Methyl Linoleate, JAOCS, vol. 81, No. 4 (2004).
Freedman, F., Butterfield, R., and Pryde, E.H. Transesterification Kinetics of Soybean Oil. JAOCS, 63(10) p. 1375 (1986).
Gan, L. H., et al (1994) Epozidized esters of palm olein as plasticizers for poly (vinyl chloride). European Polymer Journal, 31(8), 719-724.
Greenspan, F. P. et al (1953) Epoxy fatty acid ester plasticizers. Indstrial and Engineering Chemistry, 445(12), 2722-2726.
Greenspan, F.P. et al (1956), Epoxy fatty acid ester plasticizers. Preparartion and properties, The Journal of the American Oil Chemists Society, 33, 391-394.
Grummitt O. and Fleming H. Acetylated Castor Oil Industrial and Engineering Chemistry, vol. 37, No. 5, May 1945, pp. 485-491.
Haas, Michael J. Improving the Economics of biodiesel production through the use of low value lipids as feedstocks: vegetable oil soapstock, Fuel Processing Technology 86 p. 1087-96 (2005).
Jensen, R.G. Purification of Triglycerides with an Aluminca Column, Lipids, 451-452 (1966).
Morgenstern, B. “Epoxidized Fatty Acid Esters as Plasticizers for PVC” dated Apr. 22, 2005.
Morgenstern, B. Epoxidized Fatty Acid Esters as Plasticizers for PVC, presented at the 7th Freiberg Polymer Conference, Apr. 21 and 22, 2005.
Morgenstern, B. Use of Modified Fatty Acid Esters as Plasticizers for PVC, dated Sep. 12, 2003.
Opposition to patent EP2245089, Dated Jan. 9, 2013.
Orellana-Coca et al., Lipase Mediated Simultaneious Esterification and Epoxidation of Oleic Acid for the Production of Alkylepoxystearates. Journal of Molecular Catalysis B: Enzymatic 44 (2007) 133-137.
Stuart, A et al., Polym. Bull. (2010) 65:589-598.
Rehberg, C. et. Al. Plasticizers from Lactic Esters and Biabasic Acids Ind. Eng. Chem., 1952, 44 (9), pp. 2191-2195.
Santacesaria E. et al.; A Biphasic Model Describing Soybean Oil Epoxidation with H2O2 in a Fed-Batch Reactor; Chemical Engineering Journal, vol. 173, Issue 1, Sep. 1, 2011, pp. 198-209 (Elsevier B.V.).
Sen{hacek over (z)}ana S. et al.; Kinetics of In Situ Epoxidation of Soybean Oil in Bulk Catalyzed by Ion Exchange Resin; Journal of the American Oil Chemists' Society, vol. 78, No. 7 (2001) 725-731 (AOCS Press).
Sheehan, J et al. “A Look Back at the U.S. Department of Energy's Aquatic Species Program: Biodiesel from Algae”, National Renewable Energy Laboratory, Colorado, Jul. 1998, pp. 1-294.
Taylor, D. R. Proceedings of the World Conference on oilseed technology and utilization, Adsorptive Purification, American Oil Chemists Society, Champaing, 1992, p. 152-165.
Tekin A., and Hammond E. Factors Affecting the Electrical Resistivity of Soybean Oil, JAOCS, vol. 75(6) 1998.
XP002657062 Vertellus Performance Materials Inc.; Flexricin P-8 Technical Data Sheet, Nov. 2006.
XP002669860, Thomson Scientific, Mar. 13, 2009, London, GB.
PCT/US2011/041557 International Preliminary Report on Patentability, Mailed Aug. 31, 2012.
PCT/US2011/041557 International Search Report and Written Opinion Mailed Sep. 5, 2011.
PCT/US2011/045653 International Search Report and Written Opinion, Mailed Oct. 7, 2011.
PCT/US2012/043740 International Search Report and Written Opinion, Mailed Jan. 23, 2013.
PCT/US2012/055070 International Search Report and Written Opinion, Mailed Dec. 3, 2012.
PCT/US2013/023362 International Search Report and Written Opinion, Mailed Mar. 28, 2013.
PCT/US2013/023362, International Preliminary Report on Patentability, Issued Aug. 12, 2014.
PCT/US2011/059166 International Search Report and Written Opinion, Mailed Feb. 29, 2012.
PCT/US2011/059166, International Preliminary Report on Patentability, Issued May 7, 2013.
PCT/IN2012/000745 International Search Report and Written Opinion, Mailed Aug. 29, 2013.
Related Publications (1)
Number Date Country
20150337112 A1 Nov 2015 US